Pathological plasticity in fragile X syndrome

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Neuronal plasticity deficits are characteristic of neurodevelopmental disorders.
• Fragile-X syndrome (FXS), caused by FMR1 gene disruption, leads to neurological issues impacting plastic neuronal networks.

Purpose of the Study:

• To review current research on the mechanisms underlying plasticity deficits in FXS.
• To emphasize the role of these deficits during critical developmental periods and their impact on cognitive functions.

Main Methods:

• Review of existing scientific literature on fragile-X syndrome and neuronal plasticity.
• Analysis of synaptic, cell intrinsic, and homeostatic mechanisms.
• Examination of the role of metabotropic glutamate receptor transmission.

Main Results:

• FXS involves disruptions in synaptic, cell intrinsic, and homeostatic plasticity mechanisms.
• These deficits are influenced by abnormal metabotropic glutamate receptor transmission.
• Early plasticity deficits contribute to permanently reduced neuronal network adaptability.

Conclusions:

• Characterizing early developmental plasticity deficits in FXS is crucial.
• Understanding these mechanisms can inform the development of targeted therapies for FXS.
• Therapies should aim to treat symptoms and mitigate developmental pathology.